Atlas keeps focus on ‘fundamental drivers’ with new $450M fund 

Atlas Venture’s strategy will be familiar as it invests its new $450 million Fund XIII, even as macro forces in the public markets and geopolitics continue to exert stresses on the biotech industry.

The firm will continue to favor creation of platform and asset-focused companies as it deploys its largest fund yet, surpassing the $400 million Fund XII it announced in June 2020...